
Check out the companies making headlines before the bell:
Regeneron Pharmaceuticals (REGN) The drugmaker reported adjusted quarterly earnings of $23.72 per share, beating the $18.35 consensus estima… [+3524 chars]

Check out the companies making headlines before the bell:
Regeneron Pharmaceuticals (REGN) The drugmaker reported adjusted quarterly earnings of $23.72 per share, beating the $18.35 consensus estima… [+3524 chars]